Global Nuclear Medicine/Radiopharmaceuticals Market Size, Status and Forecast 2022
This report studies the global Nuclear Medicine/Radiopharmaceuticals market, analyzes and researches the Nuclear Medicine/Radiopharmaceuticals development status and forecast in United States, EU, Japan, China, India and Southeast Asia.
This report focuses on the top players in global market, like
This report focuses on the top players in global market, like
- Cardinal Health
- Mallinckrodt
- GE Healthcare
- Lantheus Medical Imaging
- Bayer
- Bracco Imaging
- Eczacibasi-Monrol Nuclear Products
- Nordion
- Advanced Accelerator Applications
- IBA Molecular Imaging
- United States
- EU
- Japan
- China
- India
- Southeast Asia
- Diagnostic (SPECT - Technetium, PET - F-18)
- Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)
- Oncology
- Thyroid
- Cardiology
Global Nuclear Medicine/Radiopharmaceuticals Market Size, Status and Forecast 2022
1 INDUSTRY OVERVIEW OF NUCLEAR MEDICINE/RADIOPHARMACEUTICALS
1.1 Nuclear Medicine/Radiopharmaceuticals Market Overview
1.1.1 Nuclear Medicine/Radiopharmaceuticals Product Scope
1.1.2 Market Status and Outlook
1.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Nuclear Medicine/Radiopharmaceuticals Market by Type
1.3.1 Diagnostic (SPECT - Technetium, PET - F-18)
1.3.2 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)
1.4 Nuclear Medicine/Radiopharmaceuticals Market by End Users/Application
1.4.1 Oncology
1.4.2 Thyroid
1.4.3 Cardiology
2 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS COMPETITION ANALYSIS BY PLAYERS
2.1 Nuclear Medicine/Radiopharmaceuticals Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 Cardinal Health
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Mallinckrodt
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 GE Healthcare
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Lantheus Medical Imaging
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Bayer
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Bracco Imaging
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Eczacibasi-Monrol Nuclear Products
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Nordion
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Advanced Accelerator Applications
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 IBA Molecular Imaging
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.10.5 Recent Developments
4 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2012-2017)
4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2012-2017)
4.3 Potential Application of Nuclear Medicine/Radiopharmaceuticals in Future
4.4 Top Consumer/End Users of Nuclear Medicine/Radiopharmaceuticals
5 UNITED STATES NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Nuclear Medicine/Radiopharmaceuticals Market Size (2012-2017)
5.2 United States Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2016 and 2017)
6 EU NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Nuclear Medicine/Radiopharmaceuticals Market Size (2012-2017)
6.2 EU Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2016 and 2017)
7 JAPAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Nuclear Medicine/Radiopharmaceuticals Market Size (2012-2017)
7.2 Japan Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2016 and 2017)
8 CHINA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DEVELOPMENT STATUS AND OUTLOOK
8.1 China Nuclear Medicine/Radiopharmaceuticals Market Size (2012-2017)
8.2 China Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2016 and 2017)
9 INDIA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DEVELOPMENT STATUS AND OUTLOOK
9.1 India Nuclear Medicine/Radiopharmaceuticals Market Size (2012-2017)
9.2 India Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size (2012-2017)
10.2 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size (Value) by Regions (2017-2022)
11.1.1 United States Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2017-2022)
11.1.2 EU Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2017-2022)
11.1.3 Japan Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2017-2022)
11.1.4 China Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2017-2022)
11.1.5 India Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2017-2022)
11.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size (Value) by Type (2017-2022)
11.3 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2017-2022)
12 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET DYNAMICS
12.1 Nuclear Medicine/Radiopharmaceuticals Market Opportunities
12.2 Nuclear Medicine/Radiopharmaceuticals Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Nuclear Medicine/Radiopharmaceuticals Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Nuclear Medicine/Radiopharmaceuticals Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
1 INDUSTRY OVERVIEW OF NUCLEAR MEDICINE/RADIOPHARMACEUTICALS
1.1 Nuclear Medicine/Radiopharmaceuticals Market Overview
1.1.1 Nuclear Medicine/Radiopharmaceuticals Product Scope
1.1.2 Market Status and Outlook
1.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Nuclear Medicine/Radiopharmaceuticals Market by Type
1.3.1 Diagnostic (SPECT - Technetium, PET - F-18)
1.3.2 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)
1.4 Nuclear Medicine/Radiopharmaceuticals Market by End Users/Application
1.4.1 Oncology
1.4.2 Thyroid
1.4.3 Cardiology
2 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS COMPETITION ANALYSIS BY PLAYERS
2.1 Nuclear Medicine/Radiopharmaceuticals Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 COMPANY (TOP PLAYERS) PROFILES
3.1 Cardinal Health
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Mallinckrodt
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 GE Healthcare
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Lantheus Medical Imaging
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Bayer
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Bracco Imaging
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Eczacibasi-Monrol Nuclear Products
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Nordion
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Advanced Accelerator Applications
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 IBA Molecular Imaging
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Nuclear Medicine/Radiopharmaceuticals Revenue (Value) (2012-2017)
3.10.5 Recent Developments
4 GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE BY TYPE AND APPLICATION (2012-2017)
4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Type (2012-2017)
4.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2012-2017)
4.3 Potential Application of Nuclear Medicine/Radiopharmaceuticals in Future
4.4 Top Consumer/End Users of Nuclear Medicine/Radiopharmaceuticals
5 UNITED STATES NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DEVELOPMENT STATUS AND OUTLOOK
5.1 United States Nuclear Medicine/Radiopharmaceuticals Market Size (2012-2017)
5.2 United States Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2016 and 2017)
6 EU NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DEVELOPMENT STATUS AND OUTLOOK
6.1 EU Nuclear Medicine/Radiopharmaceuticals Market Size (2012-2017)
6.2 EU Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2016 and 2017)
7 JAPAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DEVELOPMENT STATUS AND OUTLOOK
7.1 Japan Nuclear Medicine/Radiopharmaceuticals Market Size (2012-2017)
7.2 Japan Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2016 and 2017)
8 CHINA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DEVELOPMENT STATUS AND OUTLOOK
8.1 China Nuclear Medicine/Radiopharmaceuticals Market Size (2012-2017)
8.2 China Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2016 and 2017)
9 INDIA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DEVELOPMENT STATUS AND OUTLOOK
9.1 India Nuclear Medicine/Radiopharmaceuticals Market Size (2012-2017)
9.2 India Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2016 and 2017)
10 SOUTHEAST ASIA NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DEVELOPMENT STATUS AND OUTLOOK
10.1 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size (2012-2017)
10.2 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size and Market Share by Players (2016 and 2017)
11 MARKET FORECAST BY REGIONS, TYPE AND APPLICATION (2017-2022)
11.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size (Value) by Regions (2017-2022)
11.1.1 United States Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2017-2022)
11.1.2 EU Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2017-2022)
11.1.3 Japan Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2017-2022)
11.1.4 China Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2017-2022)
11.1.5 India Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue and Growth Rate (2017-2022)
11.2 Global Nuclear Medicine/Radiopharmaceuticals Market Size (Value) by Type (2017-2022)
11.3 Global Nuclear Medicine/Radiopharmaceuticals Market Size by Application (2017-2022)
12 NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET DYNAMICS
12.1 Nuclear Medicine/Radiopharmaceuticals Market Opportunities
12.2 Nuclear Medicine/Radiopharmaceuticals Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Nuclear Medicine/Radiopharmaceuticals Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Nuclear Medicine/Radiopharmaceuticals Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 MARKET EFFECT FACTORS ANALYSIS
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 RESEARCH FINDING/CONCLUSION
15 APPENDIX
Methodology
Analyst Introduction
Data Source
The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES
Figure Nuclear Medicine/Radiopharmaceuticals Product Scope
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) (2012-2017)
Table Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Share by Regions in 2016
Figure United States Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Share by Type in 2016
Figure Diagnostic (SPECT - Technetium, PET - F-18) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Share by Application in 2016
Table Key Downstream Customer in Oncology
Figure Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate in Oncology (2012-2017)
Table Key Downstream Customer in Thyroid
Figure Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate in Thyroid (2012-2017)
Table Key Downstream Customer in Cardiology
Figure Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate in Cardiology (2012-2017)
Table Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Players (2016 and 2017)
Figure Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2016
Figure Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2017
Table Cardinal Health Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of Cardinal Health (2012-2017)
Figure Cardinal Health Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table Mallinckrodt Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of Mallinckrodt (2012-2017)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table GE Healthcare Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of GE Healthcare (2012-2017)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table Lantheus Medical Imaging Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of Lantheus Medical Imaging (2012-2017)
Figure Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table Bayer Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of Bayer (2012-2017)
Figure Bayer Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table Bracco Imaging Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of Bracco Imaging (2012-2017)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table Eczacibasi-Monrol Nuclear Products Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of Eczacibasi-Monrol Nuclear Products (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table Nordion Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of Nordion (2012-2017)
Figure Nordion Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table Advanced Accelerator Applications Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of Advanced Accelerator Applications (2012-2017)
Figure Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table IBA Molecular Imaging Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of IBA Molecular Imaging (2012-2017)
Figure IBA Molecular Imaging Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Type (2012-2017)
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type in 2012
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type in 2013
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type in 2014
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type in 2015
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type in 2016
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type in 2017
Table Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application (2012-2017)
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application in 2012
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application in 2013
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application in 2014
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application in 2015
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application in 2016
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Nuclear Medicine/Radiopharmaceuticals
Figure United States Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Players (2012-2017)
Figure United States Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2016
Figure United States Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2017
Figure EU Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Players (2012-2017)
Figure EU Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2016
Figure EU Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2017
Figure Japan Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Players (2012-2017)
Figure Japan Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2016
Figure Japan Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2017
Figure China Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Players (2012-2017)
Figure China Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2016
Figure China Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2017
Figure India Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Players (2012-2017)
Figure India Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2016
Figure India Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2017
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2016
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2017
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Regions (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Regions (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Regions in 2017
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Regions in 2022
Figure United States Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Type (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type in 2017
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type in 2022
Table Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application in 2017
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application in 2022
Figure Nuclear Medicine/Radiopharmaceuticals Product Scope
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) (2012-2017)
Table Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Share by Regions in 2016
Figure United States Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Share by Type in 2016
Figure Diagnostic (SPECT - Technetium, PET - F-18) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Share by Application in 2016
Table Key Downstream Customer in Oncology
Figure Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate in Oncology (2012-2017)
Table Key Downstream Customer in Thyroid
Figure Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate in Thyroid (2012-2017)
Table Key Downstream Customer in Cardiology
Figure Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate in Cardiology (2012-2017)
Table Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Players (2016 and 2017)
Figure Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2016
Figure Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2017
Table Cardinal Health Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of Cardinal Health (2012-2017)
Figure Cardinal Health Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table Mallinckrodt Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of Mallinckrodt (2012-2017)
Figure Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table GE Healthcare Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of GE Healthcare (2012-2017)
Figure GE Healthcare Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table Lantheus Medical Imaging Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of Lantheus Medical Imaging (2012-2017)
Figure Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table Bayer Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of Bayer (2012-2017)
Figure Bayer Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table Bracco Imaging Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of Bracco Imaging (2012-2017)
Figure Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table Eczacibasi-Monrol Nuclear Products Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of Eczacibasi-Monrol Nuclear Products (2012-2017)
Figure Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table Nordion Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of Nordion (2012-2017)
Figure Nordion Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table Advanced Accelerator Applications Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of Advanced Accelerator Applications (2012-2017)
Figure Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table IBA Molecular Imaging Basic Information List
Table Nuclear Medicine/Radiopharmaceuticals Business Revenue (Million USD) of IBA Molecular Imaging (2012-2017)
Figure IBA Molecular Imaging Nuclear Medicine/Radiopharmaceuticals Business Revenue Market Share in 2016
Table Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Type (2012-2017)
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type in 2012
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type in 2013
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type in 2014
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type in 2015
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type in 2016
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type in 2017
Table Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application (2012-2017)
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application in 2012
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application in 2013
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application in 2014
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application in 2015
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application in 2016
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Nuclear Medicine/Radiopharmaceuticals
Figure United States Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Players (2012-2017)
Figure United States Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2016
Figure United States Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2017
Figure EU Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Players (2012-2017)
Figure EU Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2016
Figure EU Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2017
Figure Japan Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Players (2012-2017)
Figure Japan Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2016
Figure Japan Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2017
Figure China Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Players (2012-2017)
Figure China Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2016
Figure China Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2017
Figure India Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Players (2012-2017)
Figure India Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2016
Figure India Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2017
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2016
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Size Share by Players in 2017
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Regions (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Regions (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Regions in 2017
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Regions in 2022
Figure United States Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2017-2022)
Figure EU Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2017-2022)
Figure Japan Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2017-2022)
Figure China Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2017-2022)
Figure India Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2017-2022)
Figure Southeast Asia Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2017-2022)
Table Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Type (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type in 2017
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size Share by Type in 2022
Table Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application (2017-2022)
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application in 2017
Figure Global Nuclear Medicine/Radiopharmaceuticals Market Size (Million USD) by Application in 2022
